General Characteristics and Morphology
The causative agent of human cyclosporiasis is Cyclospora cayetanensis, a protozoan microorganism. Taxonomically and evolutionarily, this parasite is closely related genetically and morphologically to other significant intestinal pathogens: Isospora and Cryptosporidium parvum.
The infectious stage excreted into the environment is the oocyst. They are strictly spherical and covered by a very thick protective shell. The internal structure of a mature oocyst features two sporocysts, each containing exactly two sporozoites.
An essential criterion for differential diagnosis during microscopic examination is the size of the pathogen. The diameter of Cyclospora oocysts ranges from 8 to 10 µm. This reliably distinguishes them from related protozoa:
- They are significantly larger than Cryptosporidium parvum (which measure 4–6 µm).
- They are notably smaller than Isospora (reaching 20–35 µm in length).
Epidemiology and Pathogenesis
The infection is extremely widespread globally. Various animal groups, including reptiles, birds, and various mammals, can serve as natural reservoirs. Human infection occurs exclusively via the fecal-oral transmission route.
An important epidemiological feature that links Cyclospora to Cryptosporidium is the high resistance of their oocysts to standard drinking water disinfection methods, particularly chlorination. This allows the pathogen to persist in tap water.
Upon entering the digestive tract, the parasite localizes predominantly in the upper sections of the small intestine. Cyclospora species exhibit strict intracellular parasitism: they invade enterocytes and reside within specific cytoplasmic vacuoles. The replication of the protozoa causes pronounced pathomorphological changes in the intestinal mucosa. Local inflammation develops, accompanied by pathological atrophy of the intestinal villi and compensatory crypt hyperplasia.
Clinical Presentation
The disease caused by Cyclospora cayetanensis invasion is termed cyclosporidiosis (or cyclosporiasis). The clinically manifest form of the infection presents with two main symptoms: severe watery diarrhea and anorexia (loss of appetite).
The severity of the disease directly depends on the patient's immune status. Individuals with severe immunodeficiencies (primarily in the setting of HIV infection) constitute a high-risk group. In these patients, the disease is significantly more severe, accompanied by marked dehydration and a tendency toward a prolonged, protracted course.
Laboratory Diagnostics
The primary sample for laboratory testing is stool. Diagnostics are performed in several stages using various microscopy methods:
- Direct microscopy: Initial preparation involves native smears or preparations stained with Lugol's iodine.
- Special stains: A specific identification method is the modified Ziehl–Neelsen stain (used to detect acid-fast organisms). With this stain, acid-fast Cyclospora oocysts acquire a characteristic red color.
- Fluorescence microscopy: Modern laboratories actively evaluate autofluorescence. Cyclospora oocysts exhibit pronounced autofluorescence—they emit a bright blue glow when illuminated.
Treatment and Prevention
Specific therapy for cyclosporiasis relies on antimicrobial and antiprotozoal drugs. The main drugs of choice are a combination of trimethoprim and sulfamethoxazole, as well as metronidazole.
Prevention of the infection has no specific medical interventions and relies on strict adherence to standard general hygienic measures aimed at interrupting the fecal-oral transmission route.